Zimmer Reports Fourth Quarter and 2007 Financi... (For the Three Months Ended ...)

(Date:12/2/2008)...nced today the publication of Reproductive Health...trimester abortion: women,s health and public poli...ues regarding methods, values, stigma, the burden ... complicated reality of women,s lives and decision...ew out of a conference on second trimester abortio...

(Date:12/2/2008)...ember 1, 2008, issue of Clinical Cancer Research ... Research, show lapatinib benefits women with HER2...ative breast cancer or those who express EGRF alon...sclassification of metastatic breast cancer patien...rom receiving optimal therapy. , Lapatinib, an ...

(Date:12/2/2008)...008) The complexity of vital organ systems makes...ue culture methods for specific cell types allow r...ent parts that can be readily manipulated and obse...rotocols ( www.cshprotocols.org/TOCs/toc12_08.dtl...lture methods for cells from the immune system and...

(Date:12/2/2008)... Stroller Strides , the country,s largest and f...heir babies, has announced that Pampers , a le...ed on as the company,s premier sponsor for 2009. ,...companies, shared mission of caring for babies, to...ve Pampers as our premier sponsor," said Lisa Drux...

Breaking Medicine News(10 mins):Health News:Elsevier announces the 2008 supplement of Reproductive Health Matters 2 Health News:HER2 levels may aid in treatment selection for metastatic breast cancer 2 Health News:Cold Spring Harbor Protocols features tissue culture methods for immune cells and neurons 2 Health News:Stroller Strides(R) Signs Pampers(R) as Premier Sponsor for 2009 2

[0] Elsevier announces the 2008 supplement of Reproductive Health Matters [0] HER2 levels may aid in treatment selection for metastatic breast cancer [0] Cold Spring Harbor Protocols features tissue culture methods for immune cells and neurons [0] Stroller Strides(R) Signs Pampers(R) as Premier Sponsor for 2009

Tony Clement Canadian Health minister released the revised version of the Canada Food Guide. The new guide described as a manual on healthy lifestyle choices does exactly that, according to the healt

..., there is a pronounced increase of mental illness...Syndrome, autism spectrum disorders, obsessive// c...is study was published in the Archives of Pediatri...re not sure if this ascend could be attributed to ...

...d when his doctor discovered a potentially life-th...lood vessel, the aorta, during a routine// physica...elieved to find out that the weak spot, called an ... it was still small. For the next few years, a va...

...aunched production of unusual beer from cow's milk...g for ways to put his milk surpluses to good use./...n the store shelves Thursday, in the Japanese city...ountry's northernmost island of Hokkaido. The pr...

Other Medicine News:Health News:‘Manual on Healthy Lifestyle Choices’ Releas 2 Health News:Early Detection of Artery Weakening Can Be a Life-Saver 2 Health News:Early Detection of Artery Weakening Can Be a Life-Saver 3

‘Manual on Healthy Lifestyle Choices’ Releas Increased Mental Disorders In Children Early Detection of Artery Weakening Can Be a Life-Saver Japanese 'bilk' the Cow for Beer

(Date:12/2/2008)...LA, Calif., Dec. 2 TorreyPines The...positive results from a 26 patient Phase II trial ...r xerostomia, or dry mouth, in patients with Sjogr... a statistically significant increase in salivary ...oses: 10 mg, 15 mg, and 20 mg. These doses were sa...

(Date:12/2/2008)..., Ill., Dec. 2 Horizon Therapeutic...ny, today announced that two pivotal,Phase 3 tria...didate, HZT-501,met all primary endpoints. HZT-5...roduct containing ibuprofen and famotidine, demons...he incidence of non-steroidal,anti-inflammatory d...

(Date:12/2/2008)...DA, Md., Dec. 2 Micromet...any developing novel, proprietary antibodies for t...e diseases, today announced that it has entered in...ancing Facility (CEFF) with Kingsbridge Capital Li...s of the agreement, Kingsbridge has committed to p...

(Date:12/1/2008)...O, Dec. 2 New research ...t-slice computed tomography (CT) scanner in an eme...of stroke victims who receive a potentially life-s...t North Shore Medical Center (NSMC)-Salem Hospital...nnual meeting of the Radiological Society of North...

Breaking Medicine Technology:TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 2 TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 3 TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 4 TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 5 Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2 Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3 Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4 Micromet Expands Committed Equity Financing Facility to $75 Million 2 Micromet Expands Committed Equity Financing Facility to $75 Million 3 Micromet Expands Committed Equity Financing Facility to $75 Million 4 Micromet Expands Committed Equity Financing Facility to $75 Million 5 Micromet Expands Committed Equity Financing Facility to $75 Million 6 Portable CT Increases Chance of Stroke Survival and Recovery 2 Portable CT Increases Chance of Stroke Survival and Recovery 3 OneTouch 28R 29 Ping 28TM 29 Glucose Management System Cleared by FDA 23109 1 OneTouch 28R 29 Ping 28TM 29 Glucose Management System Cleared by FDA 23109 2 OneTouch 28R 29 Ping 28TM 29 Glucose Management System Cleared by FDA 23109 3 New technique produces genetically identical stem cells 6347 1 New technique produces genetically identical stem cells 6347 2 Sign Language Associates and Visual Language Interpreting Combine With GoAmerica to Form Nations Premier Sign Language Interpreting Services Company 23105 1 Sign Language Associates and Visual Language Interpreting Combine With GoAmerica to Form Nations Premier Sign Language Interpreting Services Company 23105 2 Sign Language Associates and Visual Language Interpreting Combine With GoAmerica to Form Nations Premier Sign Language Interpreting Services Company 23105 3 Sign Language Associates and Visual Language Interpreting Combine With GoAmerica to Form Nations Premier Sign Language Interpreting Services Company 23105 4 Sign Language Associates and Visual Language Interpreting Combine With GoAmerica to Form Nations Premier Sign Language Interpreting Services Company 23105 5 Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case 23101 1 Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case 23101 2 Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case 23101 3

[0] TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia [0] Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints [0] Micromet Expands Committed Equity Financing Facility to $75 Million [0] Portable CT Increases Chance of Stroke Survival and Recovery

...ta to be Presented April 15th at EASL Conference i...pril 11, 2007,/PRNewswire-FirstCall/ - MIGENIX Inc...ious diseases, has received new top-line results,c...s (November 6,2006) indicating evidence of clinic...study using the oral alpha-glucosidase,inhibitor, ...

...MBRIDGE, Mass.--(BUSINESS WIRE)--Apr 11, 2007 - Gl...d biopharmaceutical,company, announced today that ...omidepsin will be presented at the 2007,Annual Mee...h,taking place in Los Angeles, CA April 14-18, 200...preclinical research,performed by multiple academi...

Other Medicine Technology:New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 2 New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 3 New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 4 New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 5 New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 6 New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 7 New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 8 Gloucester Pharmaceuticals Announces Multiple Presentations of,Preclinical Romidepsin Data at American Association of Cancer,Research Annual Meeting 2 Gloucester Pharmaceuticals Announces Multiple Presentations of,Preclinical Romidepsin Data at American Association of Cancer,Research Annual Meeting 3

New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders Gloucester Pharmaceuticals Announces Multiple Presentations of,Preclinical Romidepsin Data at American Association of Cancer,Research Annual Meeting

VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients.

BD Vacutainer® Plus Plastic Serum Tubes have spray-coated silica and are used for serum determinations in chemistry, serology, and immunohematology.

Inquire

The inner wall of the tube is coated with spray-dried lithium, ammonium or sodium heparin. These additives are anti-coagulants, which activate anti-thrombins, thus blocking the coagulation cascade of

Medicine Products:

VACUETTE Paediatric Serum Tubes - Ridged (safety screw cap)BD Vacutainer® Plus Plastic Serum Tubes - Plastic MONOJECT Green Stopper VACUETTE Heparin tubes - Non-ridged (pull cap)

Zimmer Reports Fourth Quarter and 2007 Financi...(For the Three Months Ended ...),Health